English
简体中文
Total: £ 56.28
Published Date: 2025-10-15 | Pages: 165 | Tables: 173 | Medical Care
The global AI Fundus Screening System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
AI Fundus Screening System is a diagnostic tool that uses artificial intelligence to analyze images of the retina, or fundus, to detect and monitor eye conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration. By utilizing advanced algorithms, the system can identify patterns and abnormalities in the retinal images, assisting healthcare professionals in diagnosing diseases more efficiently and accurately. These systems help automate the screening process, making it accessible and scalable, especially in regions with limited access to ophthalmologists.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
AI Fundus Screening System leading manufacturers including Digital Diagnostics, Eyenuk, AEYE Health, Retinalyze, Google Health, EyRIS, Thirona Retina, VUNO, EyeCheckup, iHealthScreen, etc., dominate supply; the top five capture approximately % of global revenue, with Digital Diagnostics leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AI Fundus Screening System market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Digital Diagnostics
Eyenuk
AEYE Health
Retinalyze
Google Health
EyRIS
Thirona Retina
VUNO
EyeCheckup
iHealthScreen
iCare
Altris AI
Pr3vent
AI-Sight
Cybersight AI
RETINA-Al Health
Ping An Technology
Tencent Miying
Shenzhen Sibionics Technology
Vistel
Big Vision
Airdoc Technology
Segment by Type
Standalone System
Integrated System
Segment by Application
Hospital
Ophthalmic Clinic
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the AI Fundus Screening System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to AI Fundus Screening System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI Fundus Screening System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Standalone System
1.2.3 Integrated System
1.3 Market Segmentation by Application
1.3.1 Global AI Fundus Screening System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ophthalmic Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AI Fundus Screening System Revenue Estimates and Forecasts 2020-2031
2.2 Global AI Fundus Screening System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global AI Fundus Screening System Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global AI Fundus Screening System Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Standalone System Market Size by Players
3.3.2 Integrated System Market Size by Players
3.4 Global AI Fundus Screening System Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AI Fundus Screening System Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AI Fundus Screening System Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America AI Fundus Screening System Market Size by Type (2020-2031)
6.4 North America AI Fundus Screening System Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AI Fundus Screening System Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe AI Fundus Screening System Market Size by Type (2020-2031)
7.4 Europe AI Fundus Screening System Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AI Fundus Screening System Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific AI Fundus Screening System Market Size by Type (2020-2031)
8.4 Asia-Pacific AI Fundus Screening System Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific AI Fundus Screening System Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America AI Fundus Screening System Market Size by Type (2020-2031)
9.4 Central and South America AI Fundus Screening System Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AI Fundus Screening System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa AI Fundus Screening System Market Size by Type (2020-2031)
10.4 Middle East and Africa AI Fundus Screening System Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AI Fundus Screening System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Digital Diagnostics
11.1.1 Digital Diagnostics Corporation Information
11.1.2 Digital Diagnostics Business Overview
11.1.3 Digital Diagnostics AI Fundus Screening System Product Features and Attributes
11.1.4 Digital Diagnostics AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.1.5 Digital Diagnostics AI Fundus Screening System Revenue by Product in 2024
11.1.6 Digital Diagnostics AI Fundus Screening System Revenue by Application in 2024
11.1.7 Digital Diagnostics AI Fundus Screening System Revenue by Geographic Area in 2024
11.1.8 Digital Diagnostics AI Fundus Screening System SWOT Analysis
11.1.9 Digital Diagnostics Recent Developments
11.2 Eyenuk
11.2.1 Eyenuk Corporation Information
11.2.2 Eyenuk Business Overview
11.2.3 Eyenuk AI Fundus Screening System Product Features and Attributes
11.2.4 Eyenuk AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.2.5 Eyenuk AI Fundus Screening System Revenue by Product in 2024
11.2.6 Eyenuk AI Fundus Screening System Revenue by Application in 2024
11.2.7 Eyenuk AI Fundus Screening System Revenue by Geographic Area in 2024
11.2.8 Eyenuk AI Fundus Screening System SWOT Analysis
11.2.9 Eyenuk Recent Developments
11.3 AEYE Health
11.3.1 AEYE Health Corporation Information
11.3.2 AEYE Health Business Overview
11.3.3 AEYE Health AI Fundus Screening System Product Features and Attributes
11.3.4 AEYE Health AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.3.5 AEYE Health AI Fundus Screening System Revenue by Product in 2024
11.3.6 AEYE Health AI Fundus Screening System Revenue by Application in 2024
11.3.7 AEYE Health AI Fundus Screening System Revenue by Geographic Area in 2024
11.3.8 AEYE Health AI Fundus Screening System SWOT Analysis
11.3.9 AEYE Health Recent Developments
11.4 Retinalyze
11.4.1 Retinalyze Corporation Information
11.4.2 Retinalyze Business Overview
11.4.3 Retinalyze AI Fundus Screening System Product Features and Attributes
11.4.4 Retinalyze AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.4.5 Retinalyze AI Fundus Screening System Revenue by Product in 2024
11.4.6 Retinalyze AI Fundus Screening System Revenue by Application in 2024
11.4.7 Retinalyze AI Fundus Screening System Revenue by Geographic Area in 2024
11.4.8 Retinalyze AI Fundus Screening System SWOT Analysis
11.4.9 Retinalyze Recent Developments
11.5 Google Health
11.5.1 Google Health Corporation Information
11.5.2 Google Health Business Overview
11.5.3 Google Health AI Fundus Screening System Product Features and Attributes
11.5.4 Google Health AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.5.5 Google Health AI Fundus Screening System Revenue by Product in 2024
11.5.6 Google Health AI Fundus Screening System Revenue by Application in 2024
11.5.7 Google Health AI Fundus Screening System Revenue by Geographic Area in 2024
11.5.8 Google Health AI Fundus Screening System SWOT Analysis
11.5.9 Google Health Recent Developments
11.6 EyRIS
11.6.1 EyRIS Corporation Information
11.6.2 EyRIS Business Overview
11.6.3 EyRIS AI Fundus Screening System Product Features and Attributes
11.6.4 EyRIS AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.6.5 EyRIS Recent Developments
11.7 Thirona Retina
11.7.1 Thirona Retina Corporation Information
11.7.2 Thirona Retina Business Overview
11.7.3 Thirona Retina AI Fundus Screening System Product Features and Attributes
11.7.4 Thirona Retina AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.7.5 Thirona Retina Recent Developments
11.8 VUNO
11.8.1 VUNO Corporation Information
11.8.2 VUNO Business Overview
11.8.3 VUNO AI Fundus Screening System Product Features and Attributes
11.8.4 VUNO AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.8.5 VUNO Recent Developments
11.9 EyeCheckup
11.9.1 EyeCheckup Corporation Information
11.9.2 EyeCheckup Business Overview
11.9.3 EyeCheckup AI Fundus Screening System Product Features and Attributes
11.9.4 EyeCheckup AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.9.5 EyeCheckup Recent Developments
11.10 iHealthScreen
11.10.1 iHealthScreen Corporation Information
11.10.2 iHealthScreen Business Overview
11.10.3 iHealthScreen AI Fundus Screening System Product Features and Attributes
11.10.4 iHealthScreen AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 iCare
11.11.1 iCare Corporation Information
11.11.2 iCare Business Overview
11.11.3 iCare AI Fundus Screening System Product Features and Attributes
11.11.4 iCare AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.11.5 iCare Recent Developments
11.12 Altris AI
11.12.1 Altris AI Corporation Information
11.12.2 Altris AI Business Overview
11.12.3 Altris AI AI Fundus Screening System Product Features and Attributes
11.12.4 Altris AI AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.12.5 Altris AI Recent Developments
11.13 Pr3vent
11.13.1 Pr3vent Corporation Information
11.13.2 Pr3vent Business Overview
11.13.3 Pr3vent AI Fundus Screening System Product Features and Attributes
11.13.4 Pr3vent AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.13.5 Pr3vent Recent Developments
11.14 AI-Sight
11.14.1 AI-Sight Corporation Information
11.14.2 AI-Sight Business Overview
11.14.3 AI-Sight AI Fundus Screening System Product Features and Attributes
11.14.4 AI-Sight AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.14.5 AI-Sight Recent Developments
11.15 Cybersight AI
11.15.1 Cybersight AI Corporation Information
11.15.2 Cybersight AI Business Overview
11.15.3 Cybersight AI AI Fundus Screening System Product Features and Attributes
11.15.4 Cybersight AI AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.15.5 Cybersight AI Recent Developments
11.16 RETINA-Al Health
11.16.1 RETINA-Al Health Corporation Information
11.16.2 RETINA-Al Health Business Overview
11.16.3 RETINA-Al Health AI Fundus Screening System Product Features and Attributes
11.16.4 RETINA-Al Health AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.16.5 RETINA-Al Health Recent Developments
11.17 Ping An Technology
11.17.1 Ping An Technology Corporation Information
11.17.2 Ping An Technology Business Overview
11.17.3 Ping An Technology AI Fundus Screening System Product Features and Attributes
11.17.4 Ping An Technology AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.17.5 Ping An Technology Recent Developments
11.18 Tencent Miying
11.18.1 Tencent Miying Corporation Information
11.18.2 Tencent Miying Business Overview
11.18.3 Tencent Miying AI Fundus Screening System Product Features and Attributes
11.18.4 Tencent Miying AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.18.5 Tencent Miying Recent Developments
11.19 Shenzhen Sibionics Technology
11.19.1 Shenzhen Sibionics Technology Corporation Information
11.19.2 Shenzhen Sibionics Technology Business Overview
11.19.3 Shenzhen Sibionics Technology AI Fundus Screening System Product Features and Attributes
11.19.4 Shenzhen Sibionics Technology AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.19.5 Shenzhen Sibionics Technology Recent Developments
11.20 Vistel
11.20.1 Vistel Corporation Information
11.20.2 Vistel Business Overview
11.20.3 Vistel AI Fundus Screening System Product Features and Attributes
11.20.4 Vistel AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.20.5 Vistel Recent Developments
11.21 Big Vision
11.21.1 Big Vision Corporation Information
11.21.2 Big Vision Business Overview
11.21.3 Big Vision AI Fundus Screening System Product Features and Attributes
11.21.4 Big Vision AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.21.5 Big Vision Recent Developments
11.22 Airdoc Technology
11.22.1 Airdoc Technology Corporation Information
11.22.2 Airdoc Technology Business Overview
11.22.3 Airdoc Technology AI Fundus Screening System Product Features and Attributes
11.22.4 Airdoc Technology AI Fundus Screening System Revenue and Gross Margin (2020-2025)
11.22.5 Airdoc Technology Recent Developments
12 AI Fundus Screening SystemIndustry Chain Analysis
12.1 AI Fundus Screening System Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AI Fundus Screening System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AI Fundus Screening System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global AI Fundus Screening System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global AI Fundus Screening System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global AI Fundus Screening System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global AI Fundus Screening System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global AI Fundus Screening System Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global AI Fundus Screening System Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global AI Fundus Screening System Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global AI Fundus Screening System by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Fundus Screening System as of 2024)
Table 11. Global AI Fundus Screening System Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global AI Fundus Screening System Companies Headquarters
Table 13. Global AI Fundus Screening System Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global AI Fundus Screening System Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global AI Fundus Screening System Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global AI Fundus Screening System Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global AI Fundus Screening System Revenue by Application (2026-2031) & (US$ Million)
Table 21. AI Fundus Screening System High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America AI Fundus Screening System Growth Accelerators and Market Barriers
Table 25. North America AI Fundus Screening System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe AI Fundus Screening System Growth Accelerators and Market Barriers
Table 27. Europe AI Fundus Screening System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific AI Fundus Screening System Growth Accelerators and Market Barriers
Table 29. Asia-Pacific AI Fundus Screening System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America AI Fundus Screening System Investment Opportunities and Key Challenges
Table 31. Central and South America AI Fundus Screening System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa AI Fundus Screening System Investment Opportunities and Key Challenges
Table 33. Middle East and Africa AI Fundus Screening System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Digital Diagnostics Corporation Information
Table 35. Digital Diagnostics Description and Major Businesses
Table 36. Digital Diagnostics Product Features and Attributes
Table 37. Digital Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Digital Diagnostics Revenue Proportion by Product in 2024
Table 39. Digital Diagnostics Revenue Proportion by Application in 2024
Table 40. Digital Diagnostics Revenue Proportion by Geographic Area in 2024
Table 41. Digital Diagnostics AI Fundus Screening System SWOT Analysis
Table 42. Digital Diagnostics Recent Developments
Table 43. Eyenuk Corporation Information
Table 44. Eyenuk Description and Major Businesses
Table 45. Eyenuk Product Features and Attributes
Table 46. Eyenuk Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Eyenuk Revenue Proportion by Product in 2024
Table 48. Eyenuk Revenue Proportion by Application in 2024
Table 49. Eyenuk Revenue Proportion by Geographic Area in 2024
Table 50. Eyenuk AI Fundus Screening System SWOT Analysis
Table 51. Eyenuk Recent Developments
Table 52. AEYE Health Corporation Information
Table 53. AEYE Health Description and Major Businesses
Table 54. AEYE Health Product Features and Attributes
Table 55. AEYE Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. AEYE Health Revenue Proportion by Product in 2024
Table 57. AEYE Health Revenue Proportion by Application in 2024
Table 58. AEYE Health Revenue Proportion by Geographic Area in 2024
Table 59. AEYE Health AI Fundus Screening System SWOT Analysis
Table 60. AEYE Health Recent Developments
Table 61. Retinalyze Corporation Information
Table 62. Retinalyze Description and Major Businesses
Table 63. Retinalyze Product Features and Attributes
Table 64. Retinalyze Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Retinalyze Revenue Proportion by Product in 2024
Table 66. Retinalyze Revenue Proportion by Application in 2024
Table 67. Retinalyze Revenue Proportion by Geographic Area in 2024
Table 68. Retinalyze AI Fundus Screening System SWOT Analysis
Table 69. Retinalyze Recent Developments
Table 70. Google Health Corporation Information
Table 71. Google Health Description and Major Businesses
Table 72. Google Health Product Features and Attributes
Table 73. Google Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Google Health Revenue Proportion by Product in 2024
Table 75. Google Health Revenue Proportion by Application in 2024
Table 76. Google Health Revenue Proportion by Geographic Area in 2024
Table 77. Google Health AI Fundus Screening System SWOT Analysis
Table 78. Google Health Recent Developments
Table 79. EyRIS Corporation Information
Table 80. EyRIS Description and Major Businesses
Table 81. EyRIS Product Features and Attributes
Table 82. EyRIS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. EyRIS Recent Developments
Table 84. Thirona Retina Corporation Information
Table 85. Thirona Retina Description and Major Businesses
Table 86. Thirona Retina Product Features and Attributes
Table 87. Thirona Retina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Thirona Retina Recent Developments
Table 89. VUNO Corporation Information
Table 90. VUNO Description and Major Businesses
Table 91. VUNO Product Features and Attributes
Table 92. VUNO Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. VUNO Recent Developments
Table 94. EyeCheckup Corporation Information
Table 95. EyeCheckup Description and Major Businesses
Table 96. EyeCheckup Product Features and Attributes
Table 97. EyeCheckup Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. EyeCheckup Recent Developments
Table 99. iHealthScreen Corporation Information
Table 100. iHealthScreen Description and Major Businesses
Table 101. iHealthScreen Product Features and Attributes
Table 102. iHealthScreen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. iHealthScreen Recent Developments
Table 104. iCare Corporation Information
Table 105. iCare Description and Major Businesses
Table 106. iCare Product Features and Attributes
Table 107. iCare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. iCare Recent Developments
Table 109. Altris AI Corporation Information
Table 110. Altris AI Description and Major Businesses
Table 111. Altris AI Product Features and Attributes
Table 112. Altris AI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Altris AI Recent Developments
Table 114. Pr3vent Corporation Information
Table 115. Pr3vent Description and Major Businesses
Table 116. Pr3vent Product Features and Attributes
Table 117. Pr3vent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Pr3vent Recent Developments
Table 119. AI-Sight Corporation Information
Table 120. AI-Sight Description and Major Businesses
Table 121. AI-Sight Product Features and Attributes
Table 122. AI-Sight Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. AI-Sight Recent Developments
Table 124. Cybersight AI Corporation Information
Table 125. Cybersight AI Description and Major Businesses
Table 126. Cybersight AI Product Features and Attributes
Table 127. Cybersight AI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Cybersight AI Recent Developments
Table 129. RETINA-Al Health Corporation Information
Table 130. RETINA-Al Health Description and Major Businesses
Table 131. RETINA-Al Health Product Features and Attributes
Table 132. RETINA-Al Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. RETINA-Al Health Recent Developments
Table 134. Ping An Technology Corporation Information
Table 135. Ping An Technology Description and Major Businesses
Table 136. Ping An Technology Product Features and Attributes
Table 137. Ping An Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Ping An Technology Recent Developments
Table 139. Tencent Miying Corporation Information
Table 140. Tencent Miying Description and Major Businesses
Table 141. Tencent Miying Product Features and Attributes
Table 142. Tencent Miying Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Tencent Miying Recent Developments
Table 144. Shenzhen Sibionics Technology Corporation Information
Table 145. Shenzhen Sibionics Technology Description and Major Businesses
Table 146. Shenzhen Sibionics Technology Product Features and Attributes
Table 147. Shenzhen Sibionics Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Shenzhen Sibionics Technology Recent Developments
Table 149. Vistel Corporation Information
Table 150. Vistel Description and Major Businesses
Table 151. Vistel Product Features and Attributes
Table 152. Vistel Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Vistel Recent Developments
Table 154. Big Vision Corporation Information
Table 155. Big Vision Description and Major Businesses
Table 156. Big Vision Product Features and Attributes
Table 157. Big Vision Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Big Vision Recent Developments
Table 159. Airdoc Technology Corporation Information
Table 160. Airdoc Technology Description and Major Businesses
Table 161. Airdoc Technology Product Features and Attributes
Table 162. Airdoc Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Airdoc Technology Recent Developments
Table 164. Raw Materials Key Suppliers
Table 165. Distributors List
Table 166. Market Trends and Market Evolution
Table 167. Market Drivers and Opportunities
Table 168. Market Challenges, Risks, and Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. AI Fundus Screening System Product Picture
Figure 2. Global AI Fundus Screening System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Standalone System Product Picture
Figure 4. Integrated System Product Picture
Figure 5. Global AI Fundus Screening System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Ophthalmic Clinic
Figure 8. Others
Figure 9. AI Fundus Screening System Report Years Considered
Figure 10. Global AI Fundus Screening System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 12. Global AI Fundus Screening System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global AI Fundus Screening System Revenue Market Share by Region (2020-2031)
Figure 14. Global AI Fundus Screening System Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Standalone System Revenue Market Share by Player in 2024
Figure 17. Integrated System Revenue Market Share by Player in 2024
Figure 18. Global AI Fundus Screening System Revenue Market Share by Type (2020-2031)
Figure 19. Global AI Fundus Screening System Revenue Market Share by Application (2020-2031)
Figure 20. North America AI Fundus Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players AI Fundus Screening System Revenue (US$ Million) in 2024
Figure 22. North America AI Fundus Screening System Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America AI Fundus Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 24. US AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 25. Canada AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 27. Europe AI Fundus Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players AI Fundus Screening System Revenue (US$ Million) in 2024
Figure 29. Europe AI Fundus Screening System Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe AI Fundus Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 32. France AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 34. Italy AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 35. Russia AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific AI Fundus Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players AI Fundus Screening System Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific AI Fundus Screening System Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific AI Fundus Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 41. Japan AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 43. Australia AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 44. India AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore AI Fundus Screening System Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America AI Fundus Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players AI Fundus Screening System Revenue (US$ Million) in 2024
Figure 52. Central and South America AI Fundus Screening System Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America AI Fundus Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil AI Fundus Screening System Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina AI Fundus Screening System Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa AI Fundus Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players AI Fundus Screening System Revenue (US$ Million) in 2024
Figure 58. South America AI Fundus Screening System Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa AI Fundus Screening System Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries AI Fundus Screening System Revenue (2020-2025) & (US$ Million)
Figure 61. Israel AI Fundus Screening System Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt AI Fundus Screening System Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa AI Fundus Screening System Revenue (2020-2025) & (US$ Million)
Figure 64. AI Fundus Screening System Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
